Anupam Rasayan Maintains 30%+ Margins For Second Straight Quarter
1Anupam Rasayan's revenue increased by almost 20% on a sequential basis driven by higher volumes. EPS rose by 22% to Rs 4.61/share, doubled on a YoY basis. The company signed LOI and contracts worth Rs 2620cr in FY22.
FY23 guidance includes the company adding a new Japanese multinational company as a customer in Q1FY23, 6 new molecules to be commercialized, and CAPEX plans of Rs 2500cr.
The company has acquired a 26% stake in Tanfac, to foray into fluorination chemistry and expects a revenue potential of $260-330mn. The company also stated that the next phase of growth will be led by the fluorination segment.
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | https://bit.ly/SubscribeToETNow
To Stay Updated Download the Times Now App :-
Android Google Play : https://goo.gl/zJhWjC
Apple App Store : https://goo.gl/d7QBQZ
Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com
Subscribe Now To Our Network Channels:-
Times Now: https://bit.ly/SubscribeToTimesNow
Mirror Now: https://bit.ly/SubscribeToMirrorNow